« Back to Record
Citation APA

Jeka, S., Dokoupilová, E., Kivitz, A., Żuchowski, P., Vogg, B., Krivtsova, N., Sekhar, S., Banerjee, S., Schwebig, A., Poetzl, J., Body, J.-J., & Eastell, R. (2024). Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 39(3), 202-210. doi:10.1093/jbmr/zjae016


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/373850

Jeka, S., Dokoupilová, E., Kivitz, A., Żuchowski, P., Vogg, B., Krivtsova, N., Sekhar, S., Banerjee, S., Schwebig, A., Poetzl, J., Body, J.-J., & Eastell, R. (2024). Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 39(3), 202-210. doi:10.1093/jbmr/zjae016